Home › NDC Lookup › RxCUI directory › RxCUI 2706371

24 HR minocycline 40 MG Extended Release Oral Capsule — RxCUI 2706371

RxNorm drug concept · Semantic clinical drug
RxCUI 2706371 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2706371
Official name24 HR minocycline 40 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Minocycline Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amzeeq is specifically approved to treat inflammatory acne lesions — the red, swollen bumps — in people 9 years and older with moderate to severe acne. It's not for blackheads or w...
  • What exactly is Amzeeq used for — is it just for acne?
  • Shake the can well before each use, then dispense a small amount — roughly the size of a cherry — onto your fingertips and rub it gently into your acne-affected skin. If you have b...
  • It's worth taking seriously. The propellant that pushes the foam out of the can is flammable, so you should stay away from open flames, candles, or cigarettes while you're applying...
📖 Read our full Minocycline Topical guide →

🕸️ Concept Web — How 24 HR minocycline 40 MG Extended Release Oral Ca... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR minocycline 40 MG Extended Release Oral Capsule RxCUI 2706371

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Minocycline 6980
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emrosi 2706373
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Minocycline Extended Release Oral Capsule 384629
    • Minocycline Oral Product 1164754
    • Minocycline Pill 1164755
    • Minocycline Extended Release Oral Capsule [Emrosi] 2706377
    • Emrosi Oral Product 2706375
    • Emrosi Pill 2706376
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Minocycline 40 MG SCDC · 2706370
  • Minocycline Extended Release Oral Capsule SCDF · 384629
  • Minocycline Oral Product SCDG · 1164754
  • Minocycline Pill SCDG · 1164755

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2706371 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69489-0131-07 7 CAPSULE in 1 BOTTLE (69489-131-07) EMROSI Journey Medical Corporation 2025-03-10
69489-0131-30 30 CAPSULE in 1 BOTTLE (69489-131-30) EMROSI Journey Medical Corporation 2025-03-01
Observed labelers: Journey Medical Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.